Eczematized psoriasis–a frequent but often neglected variant of plaque psoriasis

F Lauffer, K Eyerich - JDDG: Journal der Deutschen …, 2023 - Wiley Online Library
Psoriasis is a common chronic inflammatory skin disease that causes systemic inflammation
and severely impacts the patient's quality of life. Several highly effective therapeutics for …

[HTML][HTML] Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab

M Megna, L Genco, M Noto, C Patruno… - Dermatologic …, 2022 - ncbi.nlm.nih.gov
Dear Editor, Biological drugs have completely revolutionized the management of chronic
inflammatory skin diseases, such as psoriasis. However, their use has also raised new …

[HTML][HTML] Long-Term Effectiveness of Brodalumab for the Treatment of Moderate-To-Severe Psoriasis: A Real-Life Multicenter Study of Up to 3 Years in a Real-Life …

G Caldarola, M Galluzzo, N Bernardini… - Dermatology Practical …, 2024 - ncbi.nlm.nih.gov
Objective The aim of our study was to evaluate the drug survival of brodalumab and identify
any predictive factors for discontinuation. Methods A multicenter retrospective study was …

Ekzematisierte Psoriasis–eine häufige, aber oft vernachlässigte Variante der Plaque‐Psoriasis

F Lauffer, K Eyerich - JDDG: Journal der Deutschen …, 2023 - Wiley Online Library
Psoriasis ist eine der häufigsten chronisch‐entzündlichen Hauterkrankung, die mit
systemischen Entzündungsreaktionen einhergeht und die Lebensqualität betroffener …

Author reply to: Comment on:'Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?'

A Ruggiero, M Megna, G Caiazzo… - Clinical and …, 2023 - academic.oup.com
Eczematous drug eruption during biological treatments represents novel and difficult-to-
manage reactions, with a still unexplained pathogenesis In patients treated with IL-17 …

[引用][C] Ekzematisierte Psoriasis–eine häufige, aber oft vernachlässigte Variante der Plaque-Psoriasis Eczematized psoriasis–a frequent but often neglected variant of …

F Lauffer, K Eyerich - 2023